GFC Life Science Co., Ltd (KOSDAQ:388610)
South Korea
· Delayed Price · Currency is KRW
18,100
-620 (-3.31%)
At close: Aug 13, 2025, 3:30 PM KST
GFC Life Science Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Current | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
Aug '25 Aug 14, 2025 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 |
Debt / Equity Ratio | 0.90 | 0.90 | 1.51 | 0.85 | 0.64 | 0.34 | |
Debt / EBITDA Ratio | 3.25 | 3.25 | 13.64 | 233.28 | - | - | |
Debt / FCF Ratio | 20.79 | 20.79 | - | - | - | - | |
Asset Turnover | 0.71 | 0.71 | 0.65 | 0.60 | 0.49 | 0.46 | |
Inventory Turnover | 11.18 | 11.18 | 12.84 | 11.69 | 8.75 | 9.38 | |
Quick Ratio | 0.42 | 0.42 | 0.24 | 1.46 | 1.26 | 1.43 | |
Current Ratio | 0.53 | 0.53 | 0.34 | 1.72 | 1.83 | 1.66 | |
Return on Equity (ROE) | 21.78% | 21.78% | -28.76% | 4.26% | -4.65% | -8.67% | |
Return on Assets (ROA) | 4.42% | 4.42% | -0.02% | -2.37% | -5.76% | -4.89% | |
Return on Capital (ROIC) | 5.25% | 5.25% | -0.03% | -2.58% | -6.33% | -5.33% | |
Return on Capital Employed (ROCE) | 12.50% | 12.50% | - | - | - | - | |
Buyback Yield / Dilution | 0.04% | -0.01% | -0.02% | -100.00% | 50.03% | -0.06% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.